We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$223M
AUM Growth
+$7.56M
Cap. Flow
-$5.07M
Cap. Flow %
-2.27%
Top 10 Hldgs %
34.01%
Holding
113
New
10
Increased
50
Reduced
24
Closed
15

Top Buys

Rank Stock Value
1
CB icon
Chubb
CB
+$1.01M
2
KO icon
Coca-Cola
KO
+$717K
3
MRK icon
Merck
MRK
+$682K
4
IBM icon
IBM
IBM
+$675K
5
ESRX
Express Scripts Holding Company
ESRX
+$620K

Top Sells

Rank Stock Value
1
EMR icon
Emerson Electric
EMR
+$2.2M
2
CVX icon
Chevron
CVX
+$2.11M
3
QCOM icon
Qualcomm
QCOM
+$2.03M
4
SIAL
SIGMA - ALDRICH CORP
SIAL
+$1.65M
5
EMC
EMC CORPORATION
EMC
+$1.22M

Sector Composition

Rank Sector Weight
1 Healthcare 23.26%
2 Technology 18.79%
3 Industrials 15.76%
4 Consumer Staples 9.71%
5 Energy 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
1
Procter & Gamble
PG
$349B
$9.25M 4.14%
116,507
+3,790
+3% +$290K
JNJ icon
2
Johnson & Johnson
JNJ
$609B
$8.89M 3.98%
86,564
+4,675
+6% +$470K
CVS icon
3
CVS Health
CVS
$137B
$8.79M 3.94%
89,951
+2,570
+3% +$252K
MMM icon
4
3M
MMM
$83.4B
$7.67M 3.43%
60,909
+2,823
+5% +$363K
XOM icon
5
ExxonMobil
XOM
$611B
$7.08M 3.17%
90,874
-2,292
-2% -$183K
ADP icon
6
Automatic Data Processing
ADP
$102B
$7.01M 3.14%
82,725
+3,105
+4% +$267K
NVS icon
7
Novartis
NVS
$293B
$6.96M 3.11%
90,286
-120
-0.1% -$9.53K
ATR icon
8
AptarGroup
ATR
$8.46B
$6.92M 3.1%
95,310
+3,475
+4% +$251K
HD icon
9
Home Depot
HD
$338B
$6.39M 2.86%
48,353
-549
-1% -$69.8K
INTC icon
10
Intel
INTC
$478B
$5.8M 2.6%
168,333
+1,600
+1% +$54.1K
CNI icon
11
Canadian National Railway
CNI
$78.3B
$5.79M 2.59%
103,577
-1,413
-1% -$82.6K
AAPL icon
12
Apple
AAPL
$4.9T
$5.24M 2.35%
199,236
+9,740
+5% +$278K
FISV
13
Fiserv Inc
FISV
$27B
$5.06M 2.26%
110,568
+2,600
+2% +$122K
MA icon
14
Mastercard
MA
$480B
$4.72M 2.11%
48,540
+820
+2% +$80.3K
ABT icon
15
Abbott
ABT
$175B
$4.03M 1.8%
89,670
+8,395
+10% +$371K
GOOGL icon
16
Alphabet (Google) Class A
GOOGL
$4.23T
$3.79M 1.7%
97,400
+16,080
+20% +$595K
ORCL icon
17
Oracle
ORCL
$364B
$3.73M 1.67%
102,138
+2,100
+2% +$80.2K
PEP icon
18
PepsiCo
PEP
$187B
$3.68M 1.65%
36,813
+1,130
+3% +$113K
GE icon
19
GE Aerospace
GE
$362B
$3.35M 1.5%
22,431
+528
+2% +$75K
ROK icon
20
Rockwell Automation
ROK
$51.4B
$3.35M 1.5%
32,634
-8,757
-21% -$918K
XLNX
21
DELISTED
Xilinx Inc
XLNX
$3.14M 1.41%
66,910
+895
+1% +$42.3K
EMR icon
22
Emerson Electric
EMR
$78.2B
$2.96M 1.32%
61,803
-46,280
-43% -$2.2M
NXPI icon
23
NXP Semiconductors
NXPI
$67.3B
$2.94M 1.32%
34,898
-3,435
-9% -$294K
RTX icon
24
RTX Corp
RTX
$261B
$2.75M 1.23%
45,498
-12,062
-21% -$730K
MSFT icon
25
Microsoft
MSFT
$2.93T
$2.65M 1.19%
47,742
+2,550
+6% +$134K

Similar funds

Brian C. Broderick's Q4 2015 Portfolio in Review

As of Q4 2015, Brian C. Broderick held 113 positions worth $223M, up 3.5% from $216M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Brian C. Broderick's Q4 2015 filing shows 10 new, 50 increased, 24 reduced and 15 closed positions. Its largest new stake was Express Scripts Holding Company: 7,233 shares worth $632K. The largest sale was Emerson Electric, an estimated $2.2M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.

  • Brian C. Broderick's largest Q4 2015 buy was Express Scripts Holding Company: 7,233 shares worth $632K.
  • Brian C. Broderick added most to Chubb in Q4 2015, an estimated $1.01M increase.
  • Brian C. Broderick's biggest Q4 2015 reduction was Emerson Electric, cutting an estimated $2.2M.
  • Brian C. Broderick fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $1.65M.
  • Brian C. Broderick's ten largest holdings make up 34% of its $223M portfolio in Q4 2015.
  • Brian C. Broderick opened 10 new positions and closed 15 in Q4 2015.
  • Brian C. Broderick's portfolio value rose 3.5% quarter-over-quarter to $223M.

Based on Brian C. Broderick's 13F filing for Q4 2015, filed 12 Feb 2016.